AEVIS VICTORIA SA (AEVS) AI Stock Analysis

• Market Cap: CHF1.15B
• Dividend Yield: N/A
• Average Volume (3M): 11.01K
• Price to Earnings (P/E): 550.6
• Beta (1Y): -0.11
• Revenue Growth: 9.72%
• EPS Growth: N/A
• Country: CH
• Employees: 4,731
• Sector: Services
• Sector Strength: N/A
• Industry: Medical - Care Facilities
• EPS (TTM): 0.05
• Shares Outstanding: 84,529,460
• 10 Day Avg. Volume: 5,888
• 30 Day Avg. Volume: 11,014
• PEG Ratio: 4.72
• Price to Book (P/B): 2.37
• Price to Sales (P/S): 1.24
• P/FCF Ratio: -66.90
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: CHF17.00
• Price Target Upside: 30.77% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 0.2
• Revenue Forecast (FY): CHF868.25M

• Rating: 44 Neutral
• Price Target: CHF11.00 ▼(-15.38% Downside)

AEVIS VICTORIA SA's overall stock score is primarily impacted by its financial challenges, including high leverage and net losses, and bearish technical indicators. The stock's high P/E ratio suggests overvaluation, further weighing down the score.

Positive Factors

Revenue Growth

AEVIS VICTORIA SA's consistent revenue growth reflects its expanding market presence and effective business strategies in the healthcare sector.

Operational Efficiency

Improved EBITDA margin indicates better cost management and operational efficiency, which can enhance long-term profitability.

Gross Profit Margin

A strong gross profit margin suggests effective pricing and cost control, providing a buffer against market fluctuations.

Negative Factors

High Leverage

Significant leverage can increase financial risk and limit the company's ability to invest in growth opportunities.

Persistent Net Losses

Ongoing net losses undermine financial stability and may hinder AEVIS's ability to reinvest in its business.

Negative Free Cash Flow

Negative free cash flow indicates difficulties in funding operations and growth without external financing, posing long-term financial challenges.

AEVIS VICTORIA SA Business Overview & Revenue Model

Company Description

AEVIS VICTORIA SA (AEVS) is a Swiss-based investment company primarily engaged in the healthcare sector, with a strong focus on real estate, private equity, and healthcare services. The company invests in and manages a diverse portfolio of assets, including hospitals, medical facilities, and healthcare-related businesses, aimed at enhancing the quality of care and operational efficiency in the healthcare industry. AEVIS also explores opportunities in the hospitality and wellness sectors, contributing to its multifaceted investment strategy.

How the Company Makes Money

AEVIS generates revenue through several key streams, including rental income from its real estate holdings in the healthcare sector, management fees from its private equity investments, and operational revenues from healthcare services offered through its portfolio companies. The company often enters into strategic partnerships with healthcare providers and institutions, which can enhance its service offerings and create additional revenue opportunities. Additionally, AEVIS benefits from capital appreciation of its investments as it strategically positions itself in growing markets within the healthcare and wellness industries.

AEVIS VICTORIA SA Financial Statement Overview

Summary

AEVIS VICTORIA SA shows mixed financial performance with revenue growth and operational efficiencies, but persistent net losses and high leverage pose significant risks. The company needs to improve profitability and cash flow generation.

Income Statement

AEVIS VICTORIA SA has shown a mixed performance in its income statement. The revenue growth from 2023 to 2024 was approximately 10.5%, indicating a positive trend. However, the company has been facing persistent EBIT losses, impacting its profitability. The gross profit margin for 2024 is robust at 78.2%, but the net profit margin remains negative due to net losses. EBITDA margin improved, suggesting operational efficiencies, but overall profitability remains a concern.

Balance Sheet

The company's balance sheet indicates a high debt-to-equity ratio of approximately 2.02, which suggests significant leverage. The equity ratio stands at 26.5%, reflecting moderate equity financing. Return on equity is negative due to net losses, posing a risk to financial stability. Despite these issues, the company has managed to increase its stockholders' equity over the years, showing resilience.

Cash Flow

AEVIS VICTORIA SA's cash flow statement shows challenges in generating free cash flow, which has remained negative in recent years. However, there was an improvement in operating cash flow in 2024 compared to 2023. The free cash flow to net income ratio is not favorable due to losses, and the operating cash flow to net income ratio highlights the difficulty in translating earnings into cash. The company needs to improve its cash generation to support operations and growth.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	999.58M	1.01B	914.36M	1.03B	823.26M	696.57M
Gross Profit	251.81M	789.90M	170.09M	185.41M	137.56M	112.46M
EBITDA	91.21M	92.49M	49.06M	128.29M	83.47M	34.48M
Net Income	2.09M	-2.87M	-39.30M	58.81M	-4.26M	-31.80M
Balance Sheet
Total Assets	1.93B	2.00B	1.86B	1.79B	1.73B	1.53B
Cash, Cash Equivalents and Short-Term Investments	23.52M	36.92M	80.71M	75.43M	63.42M	65.56M
Total Debt	194.29M	1.07B	1.01B	970.03M	841.27M	841.74M
Total Liabilities	1.34B	1.42B	1.32B	1.28B	1.14B	1.11B
Stockholders Equity	537.27M	530.85M	491.89M	469.34M	485.92M	361.23M
Cash Flow
Free Cash Flow	39.05M	-18.80M	-66.06M	40.28M	-24.07M	-283.46M
Operating Cash Flow	71.57M	46.50M	42.67M	114.30M	33.53M	23.77M
Investing Cash Flow	54.26M	-62.28M	35.56M	-56.82M	21.63M	-297.14M
Financing Cash Flow	-133.42M	-28.06M	-72.95M	-45.46M	-57.31M	298.71M

AEVIS VICTORIA SA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 13.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:AEVS, the sentiment is Positive. The current price of 13 is above the 20-day moving average (MA) of 12.97, below the 50-day MA of 13.05, and below the 200-day MA of 13.24, indicating a bullish trend. The MACD of 0.09 indicates Negative momentum. The RSI at 60.10 is Neutral, neither overbought nor oversold. The STOCH value of 98.04 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CH:AEVS.

AEVIS VICTORIA SA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
COTN	72 Outperform	CHF1.72B	44.07	―	0.68%	27.24%	122.39%
DKSH	70 Outperform	CHF3.69B	18.89	―	4.14%	2.66%	2.91%
ADEN	65 Neutral	CHF3.76B	13.80	―	4.46%	-4.68%	-5.79%
Sector *	55 Neutral	$13.29B	17.42	10.03%	0.93%	7.13%	-12.93%
SKAN	55 Neutral	CHF1.17B	72.55	―	0.77%	-3.45%	-49.82%
AEVS	44 Neutral	CHF1.15B	550.61	―	―	9.72%	―

AEVIS VICTORIA SA Corporate Events

AEVIS VICTORIA SA Reports Strong Revenue Growth and Strategic Review

AEVIS VICTORIA SA reported an 18.2% revenue growth in the first nine months of 2025, driven by strong performance in its healthcare and hospitality sectors. The Swiss Medical Network saw significant growth through the integration of new units, while its hospitality division benefited from Switzerland’s increasing appeal as a travel destination. The company is reviewing strategic options for its subsidiaries to support long-term development, including potential new strategic shareholders and exploring capital options for Infracore.

AEVIS VICTORIA SA Reports Strong H1 2025 Sales and Debt Reduction

AEVIS VICTORIA SA reported a significant increase in sales and free cash flow in the first half of 2025, allowing for substantial debt reduction. The company’s strategic initiatives, including the integration of Spital Zofingen and CentroMedico, have strengthened its market position, leading to sustainable growth across its healthcare and hospitality sectors. The company aims to resume its dividend policy in 2026, reflecting its improved financial health and market positioning.

AEVIS VICTORIA SA Reports Strong First Half 2025 Financial Results

AEVIS VICTORIA SA reported strong financial performance in the first half of 2025, with a 17.7% increase in consolidated gross revenue and a 17.9% rise in net revenue compared to the previous year. The company achieved significant free cash flow and reduced debt through asset sales, and anticipates positive net results, with EBITDAR and EBITDA projections indicating continued growth.